Patents Assigned to TecMed Incorporated
  • Patent number: 6370407
    Abstract: A polarimeter adapted for measurement of the concentration of glucose in a sample includes a laser beam passing through a first polarizer and an optical modulator and split into a measurement beam passing through a FIRST ANALYZER to a first detector coupled to a first amplifier and a reference beam passing through a SECOND ANALYZER to a second detector coupled to a second amplifier. Identical multiple filtering and summing operations are performed on outputs of the first and second amplifiers to produce a first &PSgr;2/2 signal and a first 2&bgr;&PSgr; signal in response to the measurement beam and a second &PSgr;2/2 signal and a second 2&bgr;&PSgr; signal in response to the reference beam. The measurement beam is stabilized by comparing the second &PSgr;2/2 signal to a first reference signal to produce a first error signal and comparing the second 2&bgr;&PSgr; signal to a second reference signal to produce a second error signal.
    Type: Grant
    Filed: June 12, 2000
    Date of Patent: April 9, 2002
    Assignee: TecMed, Incorporated
    Inventors: James K. Kroeger, Alan J. Leszinske
  • Publication number: 20010031914
    Abstract: The concentration of glucose in the anterior chamber of an eye is non-invasively measured by guiding a beam through a polarizer (4), a quarter wave plate (6), a polarization modulator (20), and an analyzer (7). After initializing the polarizer and the analyzer to extinguish the beam, it is guided parallel to the iris (56) of the eye (50) and introduced into the anterior chamber (57), wherein it is refracted, impinges on and is reflected from the iris, and exits the anterior chamber approximately collinear with the portion (55A) of the beam incident on the anterior chamber. The beam then is guided onto a detector (10), and a sufficient signal is applied to the polarization modulator to extinguish the beam. The signal represents the glucose concentration in the patient's blood.
    Type: Application
    Filed: June 8, 2001
    Publication date: October 18, 2001
    Applicant: TECMED, INCORPORATED (a New Mexico corporation)
    Inventors: Garth W. Gobeli, Alan J. Leszinske
  • Patent number: 6246893
    Abstract: The concentration of glucose in the anterior chamber of an eye is non-invasively measured by guiding a beam through a polarizer (4), a quarter wave plate (6), a polarization modulator (20), and an analyzer (7). After initializing the polarizer and the analyzer to extinguish the beam, it is guided parallel to the iris (56) of the eye (50) and introduced into the anterior chamber (57), wherein it is refracted, impinges on and is reflected from the iris, and exits the anterior chamber approximately collinear with the portion (55A) of the beam incident on the anterior chamber. The beam then is guided onto a detector (10), and a sufficient signal is applied to the polarization modulator to extinguish the beam. The signal represents the glucose concentration in the patient's blood.
    Type: Grant
    Filed: June 12, 1997
    Date of Patent: June 12, 2001
    Assignee: TecMed Incorporated
    Inventor: Garth W. Gobeli